Impact of Different <i>Helicobacter pylori</i> Eradication Therapies on Gastrointestinal Symptoms

Impact of Different <i>Helicobacter pylori</i> Eradication Therapies on Gastrointestinal Symptoms

<i>Background and Objectives</i>: <i>Helicobacter pylori (H. pylori)</i> infection impairs quality of life. However, whether eradication therapy ameliorates gastrointestinal symptoms remains questionable. The main objective of this study was to evaluate the influence of <i...

Full description

Bibliographic Details
Main Authors:	Antonio Mestrovic, Josko Bozic, Katarina Vukojevic, Ante Tonkic
Format:	Article
Language:	English
Published:	MDPI AG 2021-08-01
Series:	Medicina
Subjects:	<i>Helicobacter pylori</i> eradication therapy quality of life Gastrointestinal Symptom Rating Scale hybrid therapy concomitant therapy
Online Access:	https://www.mdpi.com/1648-9144/57/8/803

Similar Items

Randomized Clinical Trial Comparing Concomitant and Tailored Therapy for Eradication of <i>Helicobacter pylori</i> Infection
by: Nikola Perkovic, et al.
Published: (2021-06-01)

Personalized Approach in Eradication of <i>Helicobacter pylori</i> Infection
by: Antonio Mestrovic, et al.
Published: (2022-12-01)

First-line Helicobacter pylori Eradication with Standard Triple Therapy and Concomitant Therapy: A Retrospective Study
by: Moon Won Lee, et al.
Published: (2018-06-01)

Is Only Clarithromycin Susceptibility Important for the Successful Eradication of <i>Helicobacter pylori</i>?
by: Young Min Kim, et al.
Published: (2020-09-01)

Efficacy of Vonoprazan combined with high-dose Amoxicillin for eradication of <i>Helicobacter pylori</i>
by: Liu Guohua, Zhou Xian, Ye Binming, Yang Tuying, Lin Hong
Published: (2024-03-01)

Comparative Efficacy of 14-Day Tegoprazan-Based Triple vs. 10-Day Tegoprazan-Based Concomitant Therapy for <i>Helicobacter pylori</i> Eradication
by: Chan Hyuk Park, et al.
Published: (2022-11-01)

Efficacy of <i>Helicobacter pylori</i> Eradication Based on Rabeprazole–Bismuth–Tetracycline–Tinidazole Regimen in Vietnamese Patients with Duodenal Ulcers
by: Liem Thanh Nguyen, et al.
Published: (2022-10-01)

Pharmacoeconomic analysis of classic and alternative eradication therapy regimens for Helicobacter pylori
by: A. M. Veliyev, et al.
Published: (2019-05-01)

<i>Helicobacter pylori</i> Eradication Efficacy of Therapy Based on the Antimicrobial Susceptibility in Children with Gastritis and Peptic Ulcer in Mekong Delta, Vietnam
by: Loan T. T. Le, et al.
Published: (2022-07-01)

The efficacy and safety of quadruple therapy without bismuth (concomitant therapy) in the treatment of patients with Helicobacter pylori - associated gastric and duodenal peptic ulcer disease
by: A M Veliev, et al.
Published: (2019-08-01)

Effects of 14-days bismuth- and tetracycline-containing quadruple therapy with concomitant regimen for the first line Helicobacter pylori eradication
by: Arash Kazemi, et al.
Published: (2023-09-01)

Eradication of Helicobacter pylori may improve dyspepsia in the elderly for the long term
by: Ikko Tanaka, et al.
Published: (2021-11-01)

<i>Helicobacter pylori</i> induced Immune Thrombocytopenic Purpura and perspective role of <i>Helicobacter pylori</i> eradication therapy for treating Immune Thrombocytopenic Purpura
by: Arham Ihtesham, et al.
Published: (2021-09-01)

Treatment of Helicobacter pylori infection 14‐day concomitant quadruple therapy versus triple therapy: A parallel double‐blind randomized controlled trial
by: Mohamed Hichem Loghmari, et al.
Published: (2023-10-01)

Effectiveness of Rebamipide as a part of the <i>Helicobacter pylori</i> eradication therapy in Russia: a meta-analysis of controlled trials
by: Dmitry N. Andreev, et al.
Published: (2022-07-01)

Risk of Reflux-Related Symptoms and Reflux Esophagitis after <i>Helicobacter pylori</i> Eradication Treatment in the Japanese Population
by: Mitsushige Sugimoto, et al.
Published: (2021-04-01)

Current development of <i>Helicobacter pylori</i> eradication protocols
by: A. O. Pozdeeva, et al.
Published: (2022-01-01)

Can probiotics play a role in Helicobacter pylori (H. Pylori) eradication?
by: Sameh Mohamed Fakhry, et al.
Published: (2023-11-01)

Is hybrid therapy more efficient in the eradication of Helicobacter pylori infection? A systematic review and meta-analysis
by: Maria José Temido, et al.
Published: (2023-07-01)

Comparison of Sequential and Concomitant Therapy for Eradication of Helicobacter Pylori
by: Faisal Shabbir, et al.
Published: (2022-11-01)

Second-Line Bismuth-Containing Quadruple Therapy for <i>Helicobacter</i><i>pylori</i> Infection: A 12-Year Study of Annual Eradication Rates
by: Kiwon Shin, et al.
Published: (2021-07-01)

APPROBATION OF OPTIMIZED REGIMENS OF ERADICATION THERAPY PEPTIC ULCER OF THE STOMACH AND DUODENUM, ASSOCIATED WITH HELICOBACTER PYLORI
by: Amiraslanova I. T.
Published: (2019-11-01)

Rifabutin-based Fourth and Fifth-line Rescue Therapy in Patients with for Helicobacter pylori Eradication Failure
by: Jihee Sung, et al.
Published: (2017-02-01)

The Clinical Features and Helicobacter pylori Eradication Therapy in Lymphofollicular Gastritis: A Single Center Experience
by: Hong Ju An, et al.
Published: (2016-12-01)

Best <i>Helicobacter pylori</i> Eradication Strategy in the Era of Antibiotic Resistance
by: Su Young Kim, et al.
Published: (2020-07-01)

Study of probiotic and simvastatin additive effect on Helicobacter pylori eradication rate
by: Abazar Parsi, et al.
Published: (2019-10-01)

Endoscopic Reflux Esophagitis and Reflux-Related Symptoms after <i>Helicobacter pylori</i> Eradication Therapy: Meta-Analysis
by: Mitsushige Sugimoto, et al.
Published: (2020-09-01)

Eradication therapy for Helicobacter pylori infection: Review of world trends
by: I V Maev, et al.
Published: (2014-03-01)

The effect of Helicobacter pylori eradication on idiopathic chronic urticaria
by: Ali Reza Khalilian4, et al.
Published: (2009-01-01)

Clinical Implications of <i>Helicobacter pylori</i> Antibiotic Resistance in Italy: A Review of the Literature
by: Enrico Celestino Nista, et al.
Published: (2022-10-01)

Independent Risk Factors Predicting Eradication Failure of Hybrid Therapy for the First-Line Treatment of <i>Helicobacter pylori</i> Infection
by: Chien-Lin Chen, et al.
Published: (2023-12-01)

Short-duration furazolidone therapy in combination with amoxicillin, bismuth subcitrate, and omeprazole for eradication of <i>Helicobacter pylori</i>
by: Hasan Salman, et al.
Published: (2010-01-01)

Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line <em>Helicobacter pylori</em> Eradication: An Intervention Study in Southern Italy
by: Giuseppe Losurdo, et al.
Published: (2022-01-01)

Eradication Rate by Duration of Third-line Rescue Therapy with Levofloxacin after Helicobacter pylori Treatment Failure in Clinical Practice
by: Hyung Min Noh, et al.
Published: (2016-11-01)

Evaluation of the efficacy and safety of the hybrid scheme for eradication therapy of Helicobacter pylori infection
by: G L Yurenev, et al.
Published: (2018-08-01)

The effectiveness of eradication therapy of the 1st line of Helicobacter pylori infection in patients with type 2 diabetes mellitus
by: Igor V. Maev, et al.
Published: (2022-02-01)

Effect of β-caryophyllene from Cloves Extract on <i>Helicobacter pylori</i> Eradication in Mouse Model
by: Da Hyun Jung, et al.
Published: (2020-04-01)

The efficacy and mechanism of vonoprazan-containing triple therapy in the eradication of Helicobacter pylori
by: Zinan Zhang, et al.
Published: (2023-05-01)

Tailored therapy for Helicobacter pylori eradication: A systematic review and meta-analysis
by: Qin Ma, et al.
Published: (2022-09-01)

Role of Vonoprazan in Helicobacter pylori Eradication Therapy in Japan
by: Mitsushige Sugimoto, et al.
Published: (2019-01-01)